We wish to commemorate Paul Ehrlich, on the centennial of his being awarded the Nobel Prize in Physiology or Medicine in 1908. His studies are now considered as milestones in immunology: the morphology of leucocytes, his side-chain theory when he defined the cellular receptor for first time, and his clarification of the difference between serum therapy and chemotherapy. Ehrlich also invented the first chemotherapeutic drug: compound 606 or Salvarsan. We have used some original documents from the Royal Society of London, where Ehrlich was a Fellow, and from Leipzig University, where he took a degree in Medicine.
Paul Ehrlich: the Nobel Prize in Physiology or Medicine 1908
Anna Piro;Antonio Tagarelli;Giuseppe Tagarelli;Paolo Lagonia;Aldo Quattrone
2008
Abstract
We wish to commemorate Paul Ehrlich, on the centennial of his being awarded the Nobel Prize in Physiology or Medicine in 1908. His studies are now considered as milestones in immunology: the morphology of leucocytes, his side-chain theory when he defined the cellular receptor for first time, and his clarification of the difference between serum therapy and chemotherapy. Ehrlich also invented the first chemotherapeutic drug: compound 606 or Salvarsan. We have used some original documents from the Royal Society of London, where Ehrlich was a Fellow, and from Leipzig University, where he took a degree in Medicine.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prod_178952-doc_14283.pdf
solo utenti autorizzati
Descrizione: Paul Ehrlich: the Nobel Prize in Physiology or Medicine 1908
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
2.62 MB
Formato
Adobe PDF
|
2.62 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


